Hedge Funds Similar to Propel Bio

13F Portfolio OverlapQ2 2026Propel Bio portfolio →
Institutional-grade research for retail investors

Most similar hedge funds by 13F overlap

Propel Bio Management, LLC is an institutional investor managing $191M across 29 U.S. equity positions as of Q2 2026. Based on the overlap of conviction holdings in their latest 13F filings, the hedge funds with portfolios most similar to Propel Bio are Rosalind Advisors, Simplify Asset, Squadron, with shared positions in $DCTH, $CLDX, $EYPT, $OVID, $AQST, $PAGP. The full ranking of 25 similar funds is below.

Notable overlap · 5 shared positions
$379M
35 positions
Notable overlap · 7 shared positions
$7.2B
141 positions
Notable overlap · 5 shared positions
$322M
43 positions
Notable overlap · 4 shared positions
$288M
16 positions
Some overlap · 5 shared positions
$2.3B
68 positions
Some overlap · 4 shared positions
$6.9B
67 positions
Some overlap · 3 shared positions
$140M
23 positions
Some overlap · 6 shared positions
$665M
76 positions
Some overlap · 3 shared positions
$113M
25 positions
Some overlap · 3 shared positions
$136M
35 positions
Some overlap · 3 shared positions
$524M
88 positions
Some overlap · 3 shared positions
$143M
23 positions
Some overlap · 3 shared positions
$791M
149 positions
Some overlap · 3 shared positions
$4.6B
41 positions
Some overlap · 4 shared positions
$1.3B
63 positions
Some overlap · 3 shared positions
$1.1B
47 positions
Some overlap · 4 shared positions
$1.7B
33 positions
#18Caligan Partners LPSmart money
Some overlap · 4 shared positions
$2.1B
28 positions
Some overlap · 4 shared positions
$581M
84 positions
Some overlap · 4 shared positions
$510M
30 positions
Some overlap · 4 shared positions
$1.2B
24 positions
Some overlap · 4 shared positions
$439M
147 positions
#23VR Adviser, LLCSmart money
Some overlap · 4 shared positions
$3.3B
33 positions
Some overlap · 3 shared positions
$928M
156 positions
Some overlap · 3 shared positions
$604M
59 positions

Compare Propel Bio’s portfolio side by side

See the exact shared positions, conviction overlap, sector alignment, and where these funds diverge — and run the same analysis on any of 8,700+ institutions.

View Propel Bio’s holdings

Similarity is derived from each fund’s latest 13F-HR filing with the SEC. Funds are ranked by the overlap of distinctive conviction holdings; near-universal mega-cap positions are excluded so the ranking reflects shared strategy, not common index exposure. Data is informational only and not investment advice.